HIPK3
| Official symbol: | HIPK3 |
| Full name: | homeodomain interacting protein kinase 3 |
| Location: | 11p13 |
| Also known as: | PKY, FIST3, DYRK6, YAK1 |
| Entrez ID: | 10114 |
| Ensembl ID: | ENSG00000110422 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.41 | | Gscore (Del): | 0.00 |
|
|
| Recurrently amplified in 2 cancer type(s) | |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 6 |
|
|
| Fusions detected in 4 cancer type(s) |
|
| |
|
|
|
| Functional class: | Kinase (protein kinase) |
| JensenLab PubMed score: | 58.16 (Percentile rank: 64.86%) |
| PubTator score: | 22.00 (Percentile rank: 54.00%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | |
